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Abstract
Background
A high P-wave duration and dispersion (Pd) have been reported to be a prognostic factor for
the occurrence of paroxysmal atrial fibrillation (PAF), a condition linked to obstructive sleep
apnea (OSA). We tested the hypothesis of whether a short-term increase of P-wave dura-
tion and Pd can be induced by respiratory manoeuvres simulating OSA in healthy subjects
and in patients with PAF.
Methods
12-lead-electrocardiography (ECG) was recorded continuously in 24 healthy subjects and
33 patients with PAF, while simulating obstructive apnea (Mueller manoeuvre, MM),
obstructive hypopnea (inspiration through a threshold load, ITH), central apnea (AP), and
during normal breathing (BL) in randomized order. The P-wave duration and Pd was calcu-
lated by using dedicated software for ECG-analysis.
Results
P-wave duration and Pd significantly increased during MM and ITH compared to BL in all
subjects (+13.1ms and +13.8ms during MM; +11.7ms and +12.9ms during ITH; p<0.001 for
all comparisons). In MM, the increase was larger in healthy subjects when compared to
patients with PAF (p<0.05).
Conclusion
Intrathoracic pressure swings through simulated obstructive sleep apnea increase P-wave
duration and Pd in healthy subjects and in patients with PAF. Our findings imply that intra-
thoracic pressure swings prolong the intra-atrial and inter-atrial conduction time and there-
fore may represent an independent trigger factor for the development for PAF.
PLOS ONE | DOI:10.1371/journal.pone.0152994 April 12, 2016 1 / 9
a11111
OPEN ACCESS
Citation: Gaisl T, Wons AM, Rossi V, Bratton DJ,
Schlatzer C, Schwarz EI, et al. (2016) Simulated
Obstructive Sleep Apnea Increases P-Wave Duration
and P-Wave Dispersion. PLoS ONE 11(4): e0152994.
doi:10.1371/journal.pone.0152994
Editor: Thomas Penzel, Charité -
Universitätsmedizin Berlin, GERMANY
Received: December 17, 2015
Accepted: March 22, 2016
Published: April 12, 2016
Copyright: © 2016 Gaisl et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Data are available from
the University Hospital Zurich, Department of
Pulmonology after approval from the Local Ethics
Committee Zurich, Switzerland, and from the
applicant’s own institution, and with agreement from
the PI of the study Kohler M. Due to ethical reasons
and the privacy of the patients, the data are available
upon request. Requests for the data may be sent to
Malcolm.kohler@usz.ch.
Funding: This work was supported by the Clinical
Research Priority Program Sleep and Health of the
University of Zurich, Switzerland.
Introduction
Obstructive sleep apnea (OSA) is highly prevalent, with approximately 20% of males and 10%
of females in Western countries affected by asymptomatic OSA. Pathophysiologically, the dis-
ease is characterized by repetitive partial or complete obstruction of the pharynx during sleep.
Despite increasing breathing efforts the upper airway collapse results in episodes of obstructive
hypopneas or apneas resulting in negative intrathoracic pressure, intermittent hypoxia, auto-
nomic nervous dysfunction, and consequently adverse effects for sleep-architecture and health.
[1–3]
A large body of evidence suggests that OSA is associated with cardiac arrhythmias such as
paroxysmal atrial fibrillation (PAF) with some studies proposing a causal relationship.[2]
Compared with non-OSA patients, severe OSA patients have four times the odds of PAF even
after adjustment for potential confounders.[4] The underlying mechanisms of heart rhythm
disturbances induced by respiratory events is rather complex and represents a challenge in the
context of integrative human physiology. Recent studies suggested that the acute effects of
obstructive apneas may distend the atria and may change electrophysiology (especially conduc-
tion times), ultimately leading to PAF.[5–7]
Inhomogeneous atrial depolarization secondary to insults such as atrial distension or auto-
nomic nervous dysfunction can be quantified with a surface electrocardiography (ECG)-
derived P-wave analysis.[8] A high P-wave duration and P-wave dispersion (Pd) have been
reported to be a prognostic factor for the onset of PAF.[8] Moreover, the prolongation of elec-
tromechanical delay and an increased Pd are associated with the severity of OSA.[9–12]
Because treatment of OSA with continuous positive airway pressure (CPAP) provides a more
homogenous conduction (i.e. shorter P-wave durations and less Pd), a causal effect of OSA
leading to an increased risk of PAF development is possible.[13,14]
Currently, it is unclear whether hypopneas and apneas have an instant effect on P-wave dura-
tion and Pd and whether these pathophysiological events might subsequently alter atrial electro-
physiology. Thus we aimed to study this important pathophysiological link and investigate the
acute effects of simulated OSA on p-wave indices in healthy subjects and patients with PAF.
Materials and Methods
The study was approved by the “Cantonal Ethics Committee Zurich”, Switzerland (KEK-ZH-Nr.
2012–0310 / EK 1672) and written informed consent was obtained from all participants.
Study population
57 patients (24 healthy subjects and 33 patients with PAF) aged between 18 and 75 years were
recruited at the study site (University Hospital Zurich, Switzerland). The subjects overlap with
two previously published studies and sample size estimation was adopted accordingly.[5,6] In
short, these studies investigated the hypothesis whether simulated obstructive apnea could pro-
mote arrhythmias e.g. atrial premature or ventricular premature beats. [5,6] Patients with epi-
sodes of AF during the examination, therapy with class III anti-arrhythmics (e.g. amiodarone
or dronedarone), severe structural heart disease, history of atrial fibrillation ablation therapy or
lung transplantation, mental or physical disability precluding informed consent or compliance
with the protocol were excluded.
Breathing manoeuvres
The protocol for breathing manoeuvres simulating hypopneas and apneas (and therefore OSA)
which was applied in this study has been described previously.[5,6,15,16] In short, the following
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breathing manoeuvres were performed in randomized order for 20s each: (i) inspiration
through an inspiratory threshold load device (ITH) to generate a threshold pressure of
-20mmHg[15] (Threshold IMT, Respironics, NJ, USA) simulating an hypopnea; (ii) a Mueller
manoeuvre (MM) to maintain a target intrathoracic pressure of -30 mmHg[15] simulating an
obstructive apnea; (iii) a voluntary end-expiratory central apnea (AP); and (iv) a period of nor-
mal breathing which served as baseline (BL). A 60s wash-out phase between the manoeuvres
was used to ensure that the P-wave duration and Pd were similar at the beginning of each
manoeuvre. For the analysis a standardized time-frame of 50s was recorded for each manoeuvre
lasting from -10s until +40 s before and after the onset of the manoeuvre, respectively. This 50
second time-frame was also divided into five 10s sectors in which the effect of the breathing
manoeuvres on P-wave duration was assessed separately.
Electrocardiography
Digital 12-lead-ECG was recorded continuously in awake 24 healthy subjects and 33 patients
with PAF in supine position (AT 104 PC, Schiller-Reomed AG, Zurich, Switzerland). Room
temperature and lighting were set at the same level for all measurements and all subjects
remained in supine position five minutes before undergoing assessments. The beginning of the
P-wave was defined as the point where the first atrial deflection crossed the isoelectric line and
the end of the P-wave was defined as the point where the atrial deflection returned to the iso-
electric line. The maximum and minimum P-wave durations in all 12 ECG-leads were retrieved
and the most extreme ones were used to calculate the Pd (Pd = maximum P-wave duration
−minimum P-wave duration).[8] For comparisons Pd and P-wave duration was averaged
from four heartbeats at the first 10 seconds of the manoeuvre where the biggest change in
electrophysiology was expected according to previous studies.[6] We explored P-wave duration
in a single lead (II or V5) over the 50 second period of each breathing manoeuvre. All ECG
recordings were analysed offline by two investigators (TG, AMW) who were blinded to the
manoeuvre being performed using dedicated software for ECG-analysis[5] (DatInf Measure
2.1d, DatInf GmbH, Tubingen, Germany).
Statistical analysis
Continuous data were summarized as mean±SD and categorical data summarized using per-
centages. The primary outcomes of this study were the mean P-wave duration and Pd during
each breathing manoeuvre. Mixed-effects linear regression with patient-level random-inter-
cepts was used to compare the effect of each breathing manoeuvre on each outcome compared
to BL. All analyses were adjusted for manoeuvre, heart rate, BMI, age, sex, and PAF status. An
interaction between manoeuvre and PAF status was added to each model to compare the
effects of each manoeuvre in patients with and without PAF. Mixed-effects linear regression
was also used to assess the effect of each manoeuvre on Pd and P-wave duration measured in a
single lead over time by including an interaction between manoeuvre and sector.
In order to make sure our measurements were reproducible two blinded investigators each
measured a total of 180 P-waves from 20 randomly chosen sectors in which all breathing
manoeuvres were performed. Inter-observer agreement was assessed using the intra-class-cor-
relation coefficient and a Bland-Altman plot. The validity of Pd (which represents only the two
most extreme values) was checked by assessing its correlation with the standard deviation
(which takes values from all 12 leads into account) of all corresponding P-wave measurements.
A two-sided p-value less than 0.05 was considered to be statistically significant for all tests. All
statistical analyses were performed with STATA version 14 (StataCorp LP, College Station,
TX).
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Results
24 healthy subjects and 33 patients with PAF were included in this study. Clinical characteris-
tics of the study population are presented in Table 1. Compared to the healthy population, the
PAF patients were on average older (p<0.001), sleepier and tended to be more overweight
(Table 1).
P-waves
Overall results for Pd and P-wave duration are shown in Table 2. ITH and the MM signifi-
cantly increased Pd by over 10ms when compared with normal breathing (both p<0.001) in all
subjects (n = 57). ITH (-20 mmHg negative intrathoracic pressure) increased Pd by +12.9 ms
(95% CI 10.3, 15.6) and the MM (-30 mmHg negative intrathoracic pressure) by +13.8 ms
(95% CI 11.2, 16.5) when compared with BL. The P-wave duration was significantly higher
during ITH (+11.7 ms; 95% CI 9.3, 14.1) and MM (+13.1 ms; 95% CI 10.8, 15.5) when
Table 1. Clinical characteristics by study population.
Population
Characteristic Healthy (n = 24) PAF (n = 33) p-value
Age (years) 32.5 (9.9) 61.1 (11.1) <0.001
Male (%) 18 (75) 28 (85) 0.35
Height (cm) 177.2 (8.9) 176.0 (9.5) 0.63
Weight (kg) 72.5 (12.1) 82.3 (16.5) 0.012
BMI (kg/m2) 23.0 (2.7) 26.5 (4.4) <0.001
Neck Circ. (cm) 36.3 (3.9) 40.1 (4.1) 0.001
Waist/Hip ratio 0.9 (0.1) 1.0 (0.1) <0.001
ESS 5.6 (2.7) 8.6 (3.6) 0.001
RR interval (ms) 954.3 (125.6) 1033.7 (212.1) 0.083
Data summarized as mean (SD) for continuous variables and N (%) for categorical variables. Continuous variables compared between studies using
unpaired t-test. Binary variables compared between studies using χ2-test.
BMI = body-mass-index. ESS = Epworth Sleepiness Scale. PAF = paroxysmal atrial ﬁbrillation. RR interval = time from onset of one R wave to the onset
of the next R wave in the ECG.
doi:10.1371/journal.pone.0152994.t001
Table 2. Differences in P-wavemean and Pd in ms during breathingmanoeuvres in all patients (n = 57).
P-wave duration P-wave dispersion
Manoeuvre Mean (SD) Adjusted difference v BL 95% CI p-value Mean (SD) Adjusted difference v BL 95% CI p-value
BL 113.9 (10.9) - - - 27.3 (7.4) - - -
ITH 126.1 (11.4) 11.7 9.3, 14.1 <0.001 40.3 (7.9) 12.9 10.3, 15.6 <0.001
MM 126.2 (14.5) 13.1 10.8, 15.5 <0.001 41.0 (8.0) 13.8 11.2, 16.5 <0.001
AP 114.3 (10.2) -0.1 -2.5, 2.2 0.90 27.7 (6.6) 0.4 -2.3, 3.1 0.79
The ITH-manoeuvre and the MM showed a signiﬁcant increase in P-wave duration and Pd when compared to BL (normal breathing). No changes
occurred in the AP manoeuvre. All analyses were adjusted for PAF status, heart rate, age, BMI, and sex.
BL = baseline (normal breathing). ITH = inspiration through a threshold load (simulating an obstructive hypopnea). MM = Mueller manoeuvre (simulating
an obstructive apnea). AP = end-expiratory breath holding (simulating central apnea).
doi:10.1371/journal.pone.0152994.t002
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compared to BL (both p<0.001). The AP manoeuvre was not associated with significant
changes compared to BL in P-wave duration (-0.1 ms vs BL; p = 0.90) or Pd (+0.4 ms vs BL;
p = 0.79).
Fig 1 displays the mean P-wave duration in a single lead in each manoeuvre and each sector.
The P-wave duration did not change during the course of the BL (p = 0.99) and AP (p = 0.94)
manoeuvres. By contrast, there were significant increases in P-wave duration during the ITH
and MMmanoeuvres which dissipated once each manoeuvre ended with much greater
increases in the MM. Correlations coefficients between mean P-wave SD and mean Pd were:
BL = 0.98, ITH = 0.96, MM = 0.93, AP = 0.94.
Study populations
None of the healthy subjects reported usage of cardio-active medication. Patients with PAF
reported use of beta-blocker (82%), other blood pressure lowering agents (57%), and anti-
arrhythmic agents (27%). During normal breathing (BL), patients with PAF did not differ from
healthy subjects in P-wave duration (p = 1.00) and Pd (p = 0.55) after adjustment for heart
rate, age, BMI, and sex. Despite no differences in BL, non-AF individuals were more susceptible
to P-wave duration increases (p = 0.037) and Pd-increases (p = 0.009) during the MM than
patients with PAF. P-wave durations and Pd for AF and non-AF participants during each
manoeuvre are presented in Fig 2.
Fig 1. Mean P-wave durationmeasured in a single lead over all sectors (95%CI). The two sectors which comprise the manoeuvres are shaded grey. We
observed significant differences for ITH and MM vs BL during the manoeuvre (both p<0.001). The P-wave duration did not change during the course of the
BL (p = 0.99) and AP (p = 0.94) manoeuvre. All analyses were adjusted for PAF status, heart rate, age, BMI, and sex. BL = baseline (normal breathing).
ITH = inspiration through a threshold load (simulating an obstructive hypopnea). MM =Mueller manoeuvre (simulating an obstructive apnea). AP = end-
expiratory breath holding (simulating central apnea).
doi:10.1371/journal.pone.0152994.g001
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Inter-observer agreement
The intra class correlation coefficient was 0.96 (95% CI 0.95–0.98) and the 95% limits of agree-
ment were -4.49 ms / 5.10 ms showing very high inter-observer agreement in P-wave measure-
ments. For further information see S1 Appendix.
Discussion
This study is, to our knowledge, the first to investigate the acute effects of simulated apnea and
hypopnea on P-wave duration and Pd, markers of atrial conduction delay and inhomogeneous
atrial depolarization. This study provides data to better understand the pathophysiological
mechanisms that may be involved in patients with OSA and the onset of PAF. The presented
data demonstrates how simulated obstructive hypopnea (ITH) and apnea (MM) increases P-
wave duration and Pd and thus might have a direct effect on arrhythmogenesis. Our findings
that P-wave duration and Pd are increased in patients with PAF are in line with several other
studies in literature.[8]
Clinical implications
The findings of this study may have some important implications for patients at risk for PAF.
A large body of evidence suggests that OSA is linked to PAF via mechanisms like elevated
blood pressure and intermittent hypoxia among others.[2] This study, however, supports evi-
dence that the instant features of OSA directly influence markers of cardiac arrhythmic poten-
tial. P-wave duration has been shown to be highly correlated with intra-atrial conduction
times.[17] It is known that patients with OSA feature a disturbed P-wave morphology and P-
wave duration and Pd have been shown to correlate with the apnea-hypopnea index, a marker
of disease severity.[9] Animal models have shown that apneas and hypopneas themselves dis-
tend cardiac structures and alter electrophysiology.[18] This has been confirmed in several
studies conducted in humans.[5,6] Pd can be used to assess the individual propensity to PAF
Fig 2. Differences in P-wavemean and Pd during simulated obstructive sleep apnea in healthy subjects (“Non AF”, n = 24) and patients with
paroxysmal atrial fibrillation (AF, n = 33). The increase in P-wave duration (A) and Pd (B) during the MM was significantly higher in patients with PAF when
compared to healthy subjects. No significant changes were observed between the two study populations during BL and the AP manoeuvre. All analyses
were adjusted for heart rate, age, BMI, and sex. BL = baseline (normal breathing). ITH = inspiration through a threshold load (simulating an obstructive
hypopnea). MM =Mueller manoeuvre (simulating an obstructive apnea). AP = end-expiratory breath holding (simulating central apnea).
doi:10.1371/journal.pone.0152994.g002
P-Wave Dispersion in Obstructive Sleep Apnea
PLOSONE | DOI:10.1371/journal.pone.0152994 April 12, 2016 6 / 9
onset.[8] This study links the pathophysiology of OSA to altered P-wave morphology and
shows how the immediate effects of OSA have an impact on P-wave morphology. At this point,
the possibility that a significant proportion of the adult population in Western countries may
be affected by asymptomatic OSA should be kept in mind. Further research is warranted to
assess the long-term relationship between ECG-derived risk markers and the onset of PAF in
cohorts with OSA patients. Surface ECG-derived markers represent an elegant and cheap diag-
nostic tool and it has been advocated to include P-wave indices in automated ECG-reports.
Recent research suggests that the success rate of PAF treatment (i.e. pulmonary vein isola-
tion) is dependent on the diagnosis of OSA. Meta-analyses have shown that patients with OSA
have significantly greater AF recurrence rates after pulmonary vein isolation and CPAP-treat-
ment can reverse this excess risk.[19] ECG-derived risk markers might have the potential to
accurately predict PAF recurrence after ablation therapy in patients with OSA.[8] However,
this needs to be proven in future studies focused on this point.[8]
Potential mechanisms
Generally the mechanisms leading to the pathogenesis of PAF remain complex and a matter of
debate. It is thought that atrial distortion and atrial enlargement are central to the development
of PAF.[7] In our previous work, we demonstrated that instant negative intrathoracic pressure
changes contribute to cardiac dysrhythmias in healthy humans and in patients with PAF.[5,6]
Second, acute and chronic dysfunction in the autonomic nervous system associated with OSA
lead to cellular mechanisms of myocardial adaptation possibly contributing to PAF.[20] Auto-
nomic nervous system dysfunction severity (especially sympathetic over-activity) caused by
OSA on myocardial depolarization (i.e. QRS duration) is a significant clinical marker in terms
of the ventricular arrhythmic risk in OSA patients.[21] In fact, data from our study might sup-
port a potential autonomic mechanism given that PAF patients (of whom 82% were on beta-
blockers) were less susceptible to simulated OSA manoeuvres in Pd and P-wave duration. In
addition, augmented oxidative stress has been suggested to increase the risk of cardiac arrhyth-
mias.[22] In our study we could rule out any detrimental effects of instant hypoxia with the
AP-manoeuvre, based on previous experience with the manoeuvre[6]. Thus the authors
hypothesize, that intrathoracic pressure changes and autonomic nervous system dysfunction
are important mechanisms in patients with OSA contributing to atrial electrical and structural
remodeling, ultimately leading to the onset of PAF.
According to catheter measurements, approximately 85% of the airway pressure drop is
transmitted into the atria.[23] The physical effect of atrial stretch paired with autonomic ner-
vous dysfunction several hundred times per night might induce chronic atrial changes resulting
in remodeling and functional burden in patients with untreated OSA.[7] This mechanism may
be modifiable with CPAP-treatment; however this seems not to be the case with oxygen
therapy.
Strengths and limitations
The use of digital measurements, the high inter-observer agreement between blinded investiga-
tors, and the interchangeability between Pd and the SD of the measurements generate high
confidence in the validity of the data. Compared with other studies in this field, the present one
scores above average in these parametes.[8]
Given the design of this pathophysiological study it is important to emphasize that artifi-
cially induced changes in breathing patterns were evaluated which could limit the clinical rele-
vance of the data. However, the physiology of the breathing manoeuvres in our study were
validated using esophageal and aortic catheters[15] the authors feel confident that simulated
P-Wave Dispersion in Obstructive Sleep Apnea
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apneas reflect real life conditions and the results can be generalized to patients with OSA.[24]
Moreover, our team has gathered considerable experience in mimicking real-life conditions for
hypopneas and apneas.[5,6,15,16] However, we did not directly measure sympathetic activity
which might influence cardiac arrhythmic risk[21] and OSA status (i.e. sleep studies) was not
assessed in this study. Whether previous exposure to obstructive events might affect the
response of apneas on atrial conduction remains to be elucidated. Changes in autonomic ner-
vous system induced by simulated OSA in awake patients might also differ significantly from
changes during different sleep stages (e.g. rapid eye movement) which potentially limits the
generalizability of the data. Although, we excluded hypoxia (AP) as a potential mechanism in
our study[6], it is very difficult to distinguish the contribution of the role of atrial stretch versus
autonomic nervous activity and further research in this area is warranted.
Conclusion
In conclusion this study provides evidence that breathing manoeuvres simulating obstructive
sleep apnea promote an immediate increase of P-wave duration and Pd and provide a potential
explanation for the increased risk of PAF in patients with OSA. Our findings imply that intra-
thoracic pressure swings prolong the intra-atrial conduction time and therefore could be an
independent trigger factor for the development for PAF.
Supporting Information
S1 Appendix. Inter-observer agreement.
(PDF)
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